These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25652238)

  • 21. An intracellular loop 2 amino acid residue determines differential binding of arrestin to the dopamine D2 and D3 receptors.
    Lan H; Teeter MM; Gurevich VV; Neve KA
    Mol Pharmacol; 2009 Jan; 75(1):19-26. PubMed ID: 18820126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.
    Gadhe CG; Balupuri A; Cho SJ
    J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intramolecular allosteric communication in dopamine D2 receptor revealed by evolutionary amino acid covariation.
    Sung YM; Wilkins AD; Rodriguez GJ; Wensel TG; Lichtarge O
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3539-44. PubMed ID: 26979958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological Insights of the Dopaminergic Stabilizer ACR16 at the Binding Pocket of Dopamine D2 Receptor.
    Ekhteiari Salmas R; Seeman P; Aksoydan B; Stein M; Yurtsever M; Durdagi S
    ACS Chem Neurosci; 2017 Apr; 8(4):826-836. PubMed ID: 28001043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor.
    Peterson SM; Pack TF; Wilkins AD; Urs NM; Urban DJ; Bass CE; Lichtarge O; Caron MG
    Proc Natl Acad Sci U S A; 2015 Jun; 112(22):7097-102. PubMed ID: 25964346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theoretical study of 3-D molecular similarity and ligand binding modes of orthologous human and rat D2 dopamine receptors.
    Soriano-Ursúa MA; Ocampo-López JO; Ocampo-Mendoza K; Trujillo-Ferrara JG; Correa-Basurto J
    Comput Biol Med; 2011 Jul; 41(7):537-45. PubMed ID: 21621758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors.
    Kortagere S; Welsh WJ
    J Comput Aided Mol Des; 2006 Dec; 20(12):789-802. PubMed ID: 17054015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of binding residues between scorpion neurotoxins and D2 dopamine receptor: a computational docking study.
    Sudandiradoss C; George Priya Doss C; Rajasekaran R; Purohit R; Ramanathan K; Sethumadhavan R
    Comput Biol Med; 2008 Oct; 38(10):1056-67. PubMed ID: 18799158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of D₂ receptor-agonist interactions using a combination of pharmacophore and receptor homology modeling.
    Malo M; Brive L; Luthman K; Svensson P
    ChemMedChem; 2012 Mar; 7(3):471-82, 338. PubMed ID: 22315215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methods.
    Wang Q; Mach RH; Luedtke RR; Reichert DE
    J Chem Inf Model; 2010 Nov; 50(11):1970-85. PubMed ID: 20936866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: insights into the molecular determinants of telmisartan binding.
    Patny A; Desai PV; Avery MA
    Proteins; 2006 Dec; 65(4):824-42. PubMed ID: 17034041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular modelling of human 5-hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules.
    Gandhimathi A; Sowdhamini R
    J Biomol Struct Dyn; 2016 May; 34(5):952-70. PubMed ID: 26327576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations.
    Fu W; Shen J; Luo X; Zhu W; Cheng J; Yu K; Briggs JM; Jin G; Chen K; Jiang H
    Biophys J; 2007 Sep; 93(5):1431-41. PubMed ID: 17468175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mechanistic role of Helix 8 in GPCRs: Computational modeling of the dopamine D2 receptor interaction with the GIPC1-PDZ-domain.
    Sensoy O; Weinstein H
    Biochim Biophys Acta; 2015 Apr; 1848(4):976-83. PubMed ID: 25592838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding.
    Kanagarajadurai K; Malini M; Bhattacharya A; Panicker MM; Sowdhamini R
    Mol Biosyst; 2009 Dec; 5(12):1877-88. PubMed ID: 19763327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivalent approaches and beyond: novel tools for the investigation of dopamine D2 receptor pharmacology.
    Kopinathan A; Scammells PJ; Lane JR; Capuano B
    Future Med Chem; 2016 Jul; 8(11):1349-72. PubMed ID: 27357619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the Glutamate Agonist LY404,039 Binding to Nonstatic Dopamine Receptor D2 Dimer Structures and Consensus Docking.
    Salmas RE; Seeman P; Aksoydan B; Erol I; Kantarcioglu I; Stein M; Yurtsever M; Durdagi S
    ACS Chem Neurosci; 2017 Jun; 8(6):1404-1415. PubMed ID: 28272861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.